Activin has been implicated in the promotion of a CD4+/Foxp3+ phenotype in a dose‐dependent manner in both malignant (breast cancer) and non‐cancerous disease models.13, 14, 52. The gene discussed is FOXP3; the disease is breast carcinoma.